Effect of recombinant human growth hormone in elderly osteoporotic women

Clinical Endocrinology

Volumn 51, Issue 6, 1999, Pages 715-724

  Sugimoto, Toshitsugu ^a   Nakaoka, Daiki ^a   Nasu, Masamichi ^a   Kanzawa, Michiko ^a   Sugishita, Takeshi ^a   Chihara, Kazuo ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; DEOXYPYRIDINOLINE; GROWTH HORMONE; HUMAN GROWTH HORMONE; OSTEOCALCIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

AGED; ARTHRALGIA; ARTICLE; BODY COMPOSITION; BONE DENSITY; BONE MASS; BONE MINERAL; BONE TURNOVER; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOLERABILITY; EDEMA; FEMALE; GROWTH HORMONE RELEASE; HUMAN; MUSCLE STRENGTH; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; ALKALINE PHOSPHATASE; AMINO ACIDS; BIOLOGICAL MARKERS; BODY CONSTITUTION; BONE DENSITY; FEMALE; GROWTH HORMONE; HAND STRENGTH; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; STATISTICS, NONPARAMETRIC;

EID: 0033373832     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1999.00867.x     Document Type: Article

References (58)

1. Albertsson, K. & Hall, K. (1987) Growth hormone treatment in short children: relationship between growth and serum insulin-like growth factor I and II levels. Journal of Clinical Endocrinology and Metabolism, 65, 671-678.
2. Aloia, J.F., Vaswani, A., Kapoor, A., Yeh, J.K. & Cohn, S.H. (1985) Treatment of osteoporosis with calcitonin, with and without growth hormone. Metabolism, 34, 124-129.
3. Aloia, J.F., Vaswani, A. & Meunier, P.J. (1987) Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin. Calcified Tissue International, 40, 253-259.
4. Baxter, R.C. (1993) Circulating binding proteins for the insulin-like growth factors. Trends in Endocrinological Metabolism, 4, 91-96.
5. Bijlsma, J.W.J., Nortier, J.W.R., Duursma, S.A., Croughs, R.J.M., Bosch, R. & Thijssen, J.H.H. (1983) Changes in bone metabolism during treatment of acromegaly. Acta Endocrinologica (Copenh), 104, 153-159.
6. Bing-You, R.G., Denis, M.-C. & Rosen, C.J. (1993) Low bone mineral density in adults with previous hypothalamic-pituitary tumors: correlations with serum growth hormone response to GH-releasing hormone, insulin-like growth factor I, and IGF binding protein 3. Calcified Tissue International, 52, 183-187.
7. Blum, W.F., Ranke, M.B., Kietzmann, K., Gauggel, E., Zeisel, H.J. & Bierich, J.R. (1990) A specific radioimmunoassay for the growth hormone (GH) -dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. Journal of Clinical Endocrinology and Metabolism, 70, 1292-1298.
8. Boer, H.D., Blok, G.-J. & Van der Veen, E. A. (1995) Clinical aspects of growth hormone deficiency in adults. Endocrine Review, 16, 63-86.
9. Brixen, K., Nielsen, H.K., Mosekilde, L. & Flyvbjerg, A. (1990) A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers. Journal of Bone and Mineral Research, 5, 609-618.
10. Brown, J., Spanos, E. & MacIntyre, I. (1980) Role of pituitary hormones in regulating renal vitamin D metabolism in man. British Medical Journal, 280, 277-278.
11. Carroll, P.V., Christ, E.R., Bengtsson, B.A., Carlsson, L., Christiansen, J.S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., Sonksen, P.H., Tanaka, T. & Thorner, M. (1998) Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Journal of Clinical Endocrinology and Metabolism, 83, 382-395.
12. Corpas, E., Harman, S.M. & Blackman, M.R. (1992) Serum IGF-binding protein-3 is related to IGF-I, but not to spontaneous GH release in healthy old men. Hormone Metabolic Research, 24, 543-545.
13. Corpas, E., Harman, S.M. & Blackman, M.R. (1993) Human growth hormone and human aging. Endocrine Review, 14, 20-39.
14. Cuneo, R.C., Salomon, F., Wiles, C.M., Hesp, R. & Sonksen, P.H. (1991) Growth hormone treatment in growth hormone-deficient adults: effects on muscle mass and strength. Journal of Applied Physiology, 70, 688-694.
15. Daughaday, W.H., Mariz, I.K. & Blethen, S.L. (1980) Inhibition of access of bound somatomedin to membrane receptor and immuno-binding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. Journal of Clinical Endocrinology and Metabolism, 51, 781-788.
16. Diamond, T., Nery, L. & Posen, S. (1989) Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism. Annals of Internal Medicine, 111, 567-573.
17. Eriken, E.F., Kassem, M. & Brixen, K. (1993) Growth hormone and insulin-like growth factors as an anabolic therapies for osteoporosis. Hormone and Research, 40, 95-98.
18. Frolich, M., Walma, S.T., Paulson, C. & Papapoulos, S.E. (1990) Immunoradiometric assay for intact human parathyroid hormone: characteristics, clinical application and comparison with a radioimmunoassay. Annals of Clinical Biochemistry, 27, 69-72.
19. Fryburg, D.A., Gelfand, R.A. & Barrett, E.J. (1991) Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. American Journal of Physiology, 260, E499-E504.
20. Fryburg, D.A. (1994) Insulin-like growth factor I exerts growth hormone-and insulin-like actions on human muscle protein metabolism. American Journal of Physiology, 267, E331-E336.
21. Fryburg, D.A., Jahn, L.A., Hill, S.A., Oliveras, D.M. & Barrett, E.J. (1995) Insulin and insulin-like growth factor-I enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms. Journal of Clinical Investigation, 96, 1722-1729.
22. Garnero, P., Grimaux, M., Seguin, P. & Delmas, P.D. (1994) Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. Journal of Bone and Mineral Research, 9, 255-264.
23. Ghiron, L.J., Thompson, J.L., Holloway, L., Hintz, R.L., Butterfield, G.E., Hoffman, A.R. & Marcus, R. (1995) Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women. Journal of Bone and Mineral Research, 10, 1844-1852.
24. Halse, J. & Haugen, H.N. (1980) Calcium and phosphate metabolism in acromegaly. Acta Endocrinologica (Copenh), 94, 459-467.
25. Harris, W.H. & Heaney, R.P. (1969) Effect of growth hormone on skeletal mass in adult dogs. Nature, 273, 403-404.
26. Hata, K., Tokuhiro, H. & Miura, M. (1994) Precision assay of bone-type alkaline phosphatase. Japanese Journal of Clinical Chemistry [in Japanese], 23, 26-31.
27. Hata, K., Miura, M., Fukumoto, S. & Matsumoto, T. (1995) Assay of serum pyridinoline: a potent marker for bone resorption. Clinical Chimica Acta, 235, 221-227.
28. Hollis, B.W. (1986) Assay of 1,25-dihydroxyvitamin D involving a novel single-cartridge extraction and purification procedure. Clinical Chemistry, 32, 2060-2063.
29. Holloway, L., Butterfield, G., Hintz, R.L., Gesundheit, N. & Marcus, R. (1994) Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. Journal of Clinical Endocrinology and Metabolism, 79, 470-479.
30. Holloway, L., Kohlmeier, L., Kent, K. & Marcus, R. (1997) Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women. Journal of Clinical Endocrinology and Metabolism, 82, 1111-1117.
31. Holmes, S.J., Economou, G., Whitehouse, R.W., Adams, J.E. & Shalet, S.M. (1994) Reduced bone mineral density in patients with adult onset growth hormone deficiency. Journal of Clinical Endocrionology and Metabolism, 78, 669-674.
32. Holmes, S.J., Whitehouse, R.W., Economou, G., O'Halloran, D.J., Adams, J.E. & Shalet, S.M. (1995) Further increase in forearm cortical bone mineral content after discontinuation of growth hormone replacement. Clinical Endocrinology, 42, 3-7.
33. Isgaard, J., Vikman, N.K. & Isaksson, O.G.P. (1989) Growth hormone regulates the level of insulin-like growth factor-I mRNA in rat skeletal muscle. Journal of Endocrinology, 120, 107-112.
34. Johansson, A.G., Lindh, E. & Ljunghall, S. (1992) Insulin-like growth factor I stimulates bone turnover in osteoporosis. Lancet, 339, 1619.
35. Johansson, A.G., Folslund, A., Hambraeus, L., Blum, W.F. & Ljunghall, S. (1994) Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men. Journal of Bone and Mineral Research, 9, 915-921.
36. Johannsson, G., Rosen, T., Bosaeus, I., Sjostrom, L. & Bengtsson, B.-A. (1996a) Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. Journal of Clinical Endocrinology and Metabolism, 81, 2865-2873.
37. Johansson, A.G., Werner, E.L., Blum, W.F., Kollerup, G., Sorensen, O.H. & Ljunghall, S. (1996b) Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis. Journal of Clinical Endocrinology and Metabolism, 81, 44-48.
38. Johannsson, G., Marin, P., Ionn, L., Ottosson, M., Stenlof, K., Bjorntorp, P., Sjostrom, L. & Bengtsson, B.-A. (1997) Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. Journal of Clinical Endocrinology and Metabolism, 82, 727-734.
39. Kawaguchi, H., Matsumoto, T. & Kurokawa, T. (1990) Serum levels of BGP determined by two-site immunoradiometric assay (IRMA) using monoclonal antibodies. Horumon to Rinsho [in Japanese], 38, 1291-1296.
40. Lieberman, S.A., Holloway, L., Marcus, R. & Hoffman, A.R. (1994) Interactions of growth hormone and parathyroid hormone in renal phosphate, calcium, and calcitriol metabolism and bone remodeling in postmenopausal women. Journal of Bone and Mineral Research, 9, 1723-1728.
41. Nishiyama, K., Sugimoto, T., Kaji, H., Kanatani, M., Kobayashi, T. & Chihara, K. (1996) Stimulatory effect of growth hormone on bone resorption and osteoclast differentiation. Endocrinology, 137, 35-41.
42. O'Halloran, D.J., Tsatsoulis, A., Whitehouse, R.W., Holmes, S.J., Adams, J.E. & Shalet, S.M. (1993) Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. Journal of Clinical Endocrinology and Metabolism, 76, 1344-1348.
43. Papadakis, M.A., Grady, D., Black, D., Tierney, M.J., Gooding, G.A.W., Schambelan, M. & Grunfeld, C. (1996) Growth hormone replacement in healthy older men improves body composition but not functional ability. Annals of Internal Medicine, 124, 708-716.
44. Parfitt, A.M. (1991) Growth hoormone and adult bone remodeling. Clinical Endocrinology (Oxf), 35, 467-470.
45. Rosen, T., Hansson, T., Cranhed, H., Szucs, J. & Bengtsson, B.-A. (1993) Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinologica (Copenh), 129, 201-206.
46. Rosen, C.J., Donahue, L.R. & Hunter, S.J. (1994a) Insulin-like growth factors and bone: the osteoporosis connection. Experimental Biological Medicine, 206, 83-102.
47. Rosen, T., Johannsson, G., Hallgren, P., Caidahl, K., Bosaeus, I. & Bengtsson, B.-A. (1994b) Beneficial effects of 12 months replacement therapy with recombinant human growth hormone deficient adults. Endocrinology and Metabolism, 1, 55-66.
48. Rudman, D., Kutner, M.H., Rogers, C.M., Lubin, M.F., Fleming, G.A. & Bain, R.P. (1981) Impaired growth hormone secretion in the adult population. Journal of Clinical Investigation, 67, 1361-1369.
49. Rudman, D. (1985) Growth hormone, body composition and aging. Journal of American Geriatric Society, 33, 800-807.
50. Rudman, D., Feller, A., Nagraj, H.S., Gergans, G.A., Lalitha, P.Y., Goldberg, A.F., Schlenker, R.A., Cohn, L., Rudman, I.W. & Mattson, D.E. (1990) Effects of human growth hormone in men over 60 years old. New England Journal of Medicine, 323, 1-6.
51. Rudman, D., Feller, A.G., Cohn, L., Shetty, K.R., Rudman, I.W. & Draper, M.W. (1991) Effects of human growth hormone on body composition in elderly men. Hormone Research, 36 (suppl. 1), 73-81.
52. Schwander, J.C., Hauri, C., Zapf, J. & Froesch, E.R. (1983) Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology, 113, 297-305.
53. Spanos E., Barrett, D., MacIntyre, I., Pike, J.W., Safilian, E.F. & Haussler, M.R. (1978) Effect of growth hormone on vitamin D metabolism. Nature, 273, 246-247.
54. Sugimoto, T., Nishiyama, K., Kuribayashi, F. & Chihara, K. (1997) Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP) -2 and IGFBP-3 in osteoporotic patients with and without spinal fractures. Journal of Bone and Mineral Research, 12, 1272-1279.
55. Taaffe, D.R., Jin, I.H., Vu, T.H., Hoffman, A.R. & Marcus, R. (1996) Lack of effect of recombinant human growth hormone (GH) on muscle morphology and GH-insulin-like growth factor expression in resistance-trained elderly men. Journal of Clinical Endocrinology and Metabolism, 81, 421-425.
56. Thompson, J.L., Butterfield, G.E., Marcus, R., Hintz, R.L., Loan, M.V., Ghiron, L. & Hoffman, A.R. (1995) The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women. Journal of Clinical Endocrinology and Metabolism, 80, 1845-1852.
57. Turner, J.D., Rotwein, P., Novakofski, J. & Bechtel, P.J. (1988) Induction of mRNA for IGF-I and IGF-II during growth hormone-stimulated muscle hypertrophy. American Journal of Physiology, 255,E513-E517.
58. Vanweghe, M., Taelman, P. & Kaufman, J.-M. (1993) Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clinical Endocrinology, 39, 409-415.